Published in Clin Immunol Immunopathol on April 01, 1983
T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneous. Clin Exp Immunol (1985) 0.79
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med (2001) 5.59
Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (1973) 4.66
A p53-dependent mouse spindle checkpoint. Science (1995) 4.01
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med (2001) 3.98
The natural history of hereditary multiple exostoses. J Bone Joint Surg Am (1994) 3.88
Definition of a common leukocyte cell-surface antigen (Lp95-150) associated with diverse cell-mediated immune functions. J Immunol (1983) 3.70
Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res (2000) 3.64
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro. Blood (1985) 3.53
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med (1993) 3.18
Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med (1976) 3.18
Clonal origin of human tumors. Biochim Biophys Acta (1976) 3.07
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood (1998) 3.06
Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06
Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med (1977) 2.82
Elevated temperature incubation of enrichment media for the isolation of salmonellas from heavily contaminated materials. J Hyg (Lond) (1968) 2.77
Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci U S A (1974) 2.66
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med (1989) 2.61
Human tumors studied with genetic markers. Birth Defects Orig Artic Ser (1976) 2.52
Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci U S A (1967) 2.48
Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. J Immunol (1985) 2.46
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med (1998) 2.36
Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet (1999) 2.34
Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med (1985) 2.30
Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood (1986) 2.27
Mycosis fungoides palmaris et plantaris. Arch Dermatol (1995) 2.25
Primordial cell pool size and lineage relationships of five human cell types. Ann Hum Genet (1973) 2.21
Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion (1999) 2.17
Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. J Immunol (1983) 2.13
Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med (1989) 2.13
Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression. J Immunol (1985) 2.11
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood (2000) 2.11
Isolated granulomas in Hodgkin's disease. N Engl J Med (1970) 2.10
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest (1986) 2.09
Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med (1989) 2.05
The examination of samples infected with multiple salmonella serotypes. J Hyg (Lond) (1967) 2.04
Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr (1982) 2.03
A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology (2005) 2.00
A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J Immunol (1986) 1.95
Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc Natl Acad Sci U S A (1985) 1.94
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol (1990) 1.91
Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J Immunol (1986) 1.89
Neonatal cerebellar medulloblastoma originating from the fetal external granular layer. J Neuropathol Exp Neurol (1970) 1.88
Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion (1998) 1.83
Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med (1985) 1.83
Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood (1978) 1.83
Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood (1985) 1.81
Mortality hazard functions as related to neutropenia at different times after marrow transplantation. Blood (1996) 1.81
Growth and antigenic properties of a biopsy-derived Burkitt's lymphoma in thymus-less (nude) mice. Int J Cancer (1973) 1.80
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A (1996) 1.75
The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood (1997) 1.75
Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer (1971) 1.74
The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology (2005) 1.74
The origin and development of human tumors studied with cell markers. N Engl J Med (1974) 1.73
The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest (1994) 1.69
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet (1995) 1.69
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood (1997) 1.65
Comparison of selenite F, Muller-Kauffmann tetrathionate and Rappaport's medium for the isolation of salmonellas from sewage-polluted natural water using a pre-enrichment technique. J Hyg (Lond) (1979) 1.65
A receptor for IgA on human T lymphocytes. J Immunol (1979) 1.65
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64
Absence of monoclonal-antibody-defined protein complex in boy with abnormal leucocyte function. Lancet (1984) 1.63
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood (1987) 1.63
Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood (1991) 1.63
"Immunologic" oncogenesis. Blood (1967) 1.61
Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med (1992) 1.61
Epidemiology of lymphomatoid papulosis. Cancer (1992) 1.60
Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol (1996) 1.60
Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol (1998) 1.59
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Properties of CeO2 thin films prepared by oxygen-ion-assisted deposition. Appl Opt (1985) 1.54
Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin. J Clin Invest (1978) 1.53
Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes. J Clin Invest (1986) 1.53
The kinetics of immune reconstitution after human marrow transplantation. Blood (1987) 1.52
Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep (1982) 1.51
Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes. Eur J Immunol (1985) 1.51
Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med (1978) 1.51
T cell activation modulates retrovirus-mediated gene expression. Hum Gene Ther (1998) 1.50
Frequency of immediate adverse effects associated with apheresis donation. Transfusion (1998) 1.49
A method of secondary enrichment for salmonellas independent of selectively toxic chemicals. J Hyg (Lond) (1966) 1.49
Salmonellas of subgenus 3 (Arizona) isolated from abattoirs in England and Wales. J Hyg (Lond) (1966) 1.49
Erythrophagocytic T gamma lymphoma: a clinicopathologic entity resembling malignant histiocytosis. N Engl J Med (1981) 1.48
Mechanism of synthesis of D-glucans by D-glucosyltransferases from Streptococcus mutans 6715. Carbohydr Res (1983) 1.47
Use of genetic markers to study cellular origin and development of tumors in human females. Adv Cancer Res (1972) 1.46
In vitro regulation of immunoglobulin synthesis by T-cell subpopulations defined by a new human T-cell antigen (9.3). Cell Immunol (1982) 1.46
Clinical relevance of intraoperative embolization detected by transcranial Doppler ultrasonography during carotid endarterectomy: a prospective study of 100 patients. Br J Surg (1994) 1.46
A new medium for isolating Campylobacter jejuni/coli. J Clin Pathol (1982) 1.46